Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Baxter
Dow
AstraZeneca
Moodys

Last Updated: January 27, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Laninamivir


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Laninamivir?

Laninamivir is an investigational drug.

There have been 4 clinical trials for Laninamivir. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2013.

The most common disease conditions in clinical trials are Influenza, Human, Asthma, and [disabled in preview]. The leading clinical trial sponsors are Biota Scientific Management Pty Ltd, Department of Health and Human Services, and National Institute of Allergy and Infectious Diseases (NIAID).

There are one hundred and fifty-four US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Laninamivir
TitleSponsorPhase
Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With InfluenzaDepartment of Health and Human ServicesPhase 1/Phase 2
Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With InfluenzaBiota Scientific Management Pty LtdPhase 1/Phase 2
Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic AsthmaDepartment of Health and Human ServicesPhase 1

See all Laninamivir clinical trials

Clinical Trial Summary for Laninamivir

Top disease conditions for Laninamivir
Top clinical trial sponsors for Laninamivir

See all Laninamivir clinical trials

US Patents for Laninamivir

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Laninamivir ⤷  Try it Free RSV G protein specific antibodies AIMM THERAPEUTICS B.V. (Amsterdam, NL) ⤷  Try it Free
Laninamivir ⤷  Try it Free Methods and compositions for inhibition of polymerase BioCryst Pharmaceuticals, Inc. (Durham, NC) ⤷  Try it Free
Laninamivir ⤷  Try it Free Synergistic antiviral composition and use thereof MARINOMED BIOTECHNOLOGIE GmbH (Vienna, AT) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Laninamivir

Drugname Country Document Number Estimated Expiration Related US Patent
Laninamivir European Patent Office EP2780366 2031-11-17 ⤷  Try it Free
Laninamivir World Intellectual Property Organization (WIPO) WO2013095091 2031-11-17 ⤷  Try it Free
Laninamivir Australia AU2011315902 2030-10-15 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Baxter
Dow
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.